IFNG and in situ carcinoma: To determine whether CIS was needed to protect from tumour progression, we explicitly focussed only on 19 genes of the panel that encode for molecules that are also involved in the IFN-γ-mediated activation of the senescence signalling pathways that we identified in our murine experiments.